Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases-Reference-Cited by-同舟云学术

Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases

Published:2011-05 Issue:5 Volume:35 Page:608-613
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Noor Syed J.,Tan Wei,Wilding Gregory E.,Ford Laurie A.,Barcos Maurice,Sait Sheila N.J.,Block AnneMarie W.,Thompson James E.,Wang Eunice S.,Wetzler Meir

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference61 articles.

1. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis;Anastasi;Hematol Oncol Clin North Am,2009

2. Leukemic transformation of polycythemia vera: a single center study of 23 patients;Passamonti;Cancer,2005

3. Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients;Cervantes;Acta Haematol,1991

4. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases;Mesa;Blood,2005

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Polystemia Vera Patients Diagnosed Before and After the Updated Diagnostic Criteria;OSMANGAZİ JOURNAL OF MEDICINE;2024-03-11

2. Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?;Folia Medica;2023-10-31

3. Liquid biopsies and minimal residual disease in myeloid malignancies;Frontiers in Oncology;2023-05-05

4. Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-09

5. Accelerated and blast phase myeloproliferative neoplasms;Best Practice & Research Clinical Haematology;2022-06